Stylli lands CEO post at Sequenom

Harry Stylli, former CEO at Xencor, will take over as CEO of Sequenom. Stylli remains a director of Xencor and is the founder of Aurora Biosciences. He replaces Antonius Schuh, who resigned in February. Company CFO Stephen Zaniboni has been acting CEO in the interim.

- read this story from Marketwatch on the appointment

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.